WHO vaccine-preventable diseases: monitoring system. 2017 global summary

Last updated 06-Sep-2017 (data as of 05-Sep-2017)
Next overall update 2018
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 6'6701 Infant (under 12 months) mortality rate: 172
GDP / capita (US$): 11'0281 Child (under 5 years) mortality rate: 182

Population data in thousands3

  2016  2015  2014  2013  2012  2000  1990  1980 
Total population 110  109  109  109  109  108  108  101 
Births
Surviving infants
Pop. less than 5 years 11  13  15 
Pop. less than 15 years 26  27  27  28  28  34  41  44 
Female 15-49 years 29  29  29  29  29  28  25  23 

Number of reported cases

(Click for retrospective incidence data for Saint Vincent and the Grenadines)
Diphtheria
ChartChart
 
Japanese encephalitis
 
Measles
ChartChart ChartChart
  257 
Mumps
ChartChart
 
Pertussis
ChartChart
 
Polio*
ChartChart
 
Rubella
ChartChart
 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
 
Tetanus (total)**
ChartChart
 
Yellow fever
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For disaggregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Saint Vincent and the Grenadines)
Vaccine year result method % card seen                                                
BCG          99*  99*  96  97  99*  99* 
DTP1          98  99*  99*  96  94  91 
DTP3          99*  99*  98  99*  96  99*  98  26 
DTP4          99*  97  97 
IPV1          99  90  99* 
HepB_BD          99*  20 
HepB3          99*  99*  98  99*  96 
Hib3          99*  99*  98  99*  97 
JapEnc         
MCV1          99*  99*  99*  99*  94  96  96 
MCV2          99*  99  98  96  92 
MenA         
PCV1         
PCV2         
PCV3         
Pol3          99*  99*  97  99*  96  99*  92  26 
Rota1         
RotaC         
RCV1          99*  99*  99*  99*  94 
TT2plus          12  10  11 
PAB          99*  99* 
VAD1         
YFV          10 
* indicates the country reported above 100% coverage.

  Next update: Mid-July 2018

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Saint Vincent and the Grenadines)
BCG
ChartChart
  99  99  98  96  97  99  99 
DTP1
ChartChart
  99  99  99  99  98  99  98  51 
DTP3
ChartChart
  98  98  98  97  96  98  98  26 
HepB3
ChartChart
  98  98  98  97  96 
HepB_BD
ChartChart
 
Hib3
ChartChart
  99  99  98  98  97 
IPV1
  99  54 
MCV1
ChartChart
  99  99  99  99  94  96  96 
MCV2
ChartChart
  99  99  98  96  92 
PCV3
 
Pol3
ChartChart
  97  97  97  97  96  99  92  26 
RCV1
ChartChart
  99  99  99  99  94  96 
RotaC
 

Click for WHO-UNICEF coverage estimates data for PAB time series.

Number of districts in the country Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 67
From 80 to 89% 33
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2016 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DT 4 years; Yes
DTwP 18 months; Yes
DTwPHibHepB 2, 4, 6 months; Yes
HPV Yes From September 2017
IPV 2, 4 months; Yes
MMR 1, 4 years; Yes
OPV 6, 18 months; Yes
Td 10 years; Yes
YF 1st contact; Yes travelers

Immunizaton indicators

Indicator Expected answer 2016  2015  2014  2013  2012  2011  2010 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR No  No  No  No  No  No  No 
What years does the MYP cover? number NA             
Nº of districts with microplans that include activities to raise immunization coverage number

System performance

Total Nº districts in country number
Nº districts with DTP3 coverage >=80% number
% of districts with DTP3 coverage >=80% From 0 to 100% 100  100  100  100  89  100  100 
Nº districts with measles (MCV1) coverage >=95% number
% of districts with MCV1 coverage >=95% From 0 to 100% 78  100  89  56  56  78  56 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND No  No  No  No  No  No  No 
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

% of Immunization expenditure financed, using Government funds? From 0 to 100% 89  87  94  100  100  100  100 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR No  No  No  No  No  No  No 

Sources

 1  "The 2017 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2016, data for 2015
 3  "United Nations, Population Division. The World Population Prospects - the 2017 revision". New York, 2017.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.